{"id":16,"date":"2026-03-15T23:01:59","date_gmt":"2026-03-15T22:01:59","guid":{"rendered":"https:\/\/themedicaltribune.com\/tr\/2026\/03\/15\/50-yas-alti-gencler-neden-kalp-hastaliklarindan-oluyor\/"},"modified":"2026-03-15T23:02:33","modified_gmt":"2026-03-15T22:02:33","slug":"50-yas-alti-gencler-neden-kalp-hastaliklarindan-oluyor","status":"publish","type":"post","link":"https:\/\/themedicaltribune.com\/tr\/2026\/03\/15\/50-yas-alti-gencler-neden-kalp-hastaliklarindan-oluyor\/","title":{"rendered":"50 ya\u015f alt\u0131 gen\u00e7ler neden kalp hastal\u0131klar\u0131ndan \u00f6l\u00fcyor?"},"content":{"rendered":"

50 ya\u015f alt\u0131 gen\u00e7ler neden kalp hastal\u0131klar\u0131ndan \u00f6l\u00fcyor?<\/h1>\n

Almanya’da on y\u0131l boyunca yap\u0131lan adli otopsilerin derinlemesine analizi, 50 ya\u015f alt\u0131ndaki do\u011fal \u00f6l\u00fcmlerin yakla\u015f\u0131k d\u00f6rtte birinin kalp k\u00f6kenli oldu\u011funu ortaya koyuyor. Bu vakalarda, \u00f6zellikle 40-49 ya\u015f aras\u0131 erkekleri etkileyen iskemik kalp hastal\u0131klar\u0131 ba\u015f\u0131 \u00e7ekiyor. Bu sonu\u00e7lar, erken kalp risklerinin daha iyi anla\u015f\u0131lmas\u0131n\u0131n ve buna g\u00f6re hareket edilmesinin \u00f6nemini vurguluyor.<\/p>\n

Ara\u015ft\u0131rmac\u0131lar, 2014 ile 2023 y\u0131llar\u0131 aras\u0131nda yap\u0131lan 9.000’den fazla otopsiyi inceledi. Yap\u0131sal kalp anormalli\u011fi nedeniyle \u00f6len 0-49 ya\u015f aras\u0131 192 ki\u015fiye odakland\u0131lar. Kalp kas\u0131na kan ak\u0131\u015f\u0131n\u0131n azalmas\u0131yla ortaya \u00e7\u0131kan iskemik hastal\u0131klar, bu ya\u015f grubundaki kalp \u00f6l\u00fcmlerinin yakla\u015f\u0131k %40’\u0131n\u0131 olu\u015fturuyordu. Bu hastal\u0131klar genellikle kalbe oksijen ta\u015f\u0131nmas\u0131n\u0131 s\u0131n\u0131rlayan ya\u011f birikintileriyle t\u0131kanm\u0131\u015f koronar arterlerle ili\u015fkilidir.<\/p>\n

\u00c7al\u0131\u015fma, kurbanlar\u0131n kalp a\u011f\u0131rl\u0131\u011f\u0131n\u0131n ortalaman\u0131n \u00fczerinde oldu\u011funu da g\u00f6steriyor. Hipertrofi ad\u0131 verilen bu durum, y\u00fcksek tansiyon, yo\u011fun fiziksel efor veya genetik hastal\u0131klardan kaynaklanabilir. \u00c7ok a\u011f\u0131r olan bir kalp daha fazla \u00e7al\u0131\u015fmak zorunda kal\u0131r, bu da aritmi veya kalp krizi riskini art\u0131r\u0131r.<\/p>\n

\u00d6len ki\u015filerde sigara i\u00e7me, a\u015f\u0131r\u0131 kilo ve obezite gibi klasik risk fakt\u00f6rleri s\u0131k g\u00f6r\u00fcl\u00fcyordu. \u0130skemik hastal\u0131\u011f\u0131 olanlar\u0131n \u00fc\u00e7te ikisinden fazlas\u0131nda fazla kilo vard\u0131. Sigara i\u00e7me oran\u0131 da genel n\u00fcfusa g\u00f6re daha y\u00fcksekti; kurbanlar\u0131n %40’tan fazlas\u0131 sigara i\u00e7iyordu.<\/p>\n

\u00d6l\u00fcm \u00f6ncesi belirtiler de\u011fi\u015fkenlik g\u00f6steriyordu: baz\u0131lar\u0131 g\u00f6\u011f\u00fcs a\u011fr\u0131s\u0131 veya nefes darl\u0131\u011f\u0131 hissediyordu, ancak baz\u0131lar\u0131nda hi\u00e7bir \u00f6n belirtinin olmad\u0131\u011f\u0131 g\u00f6r\u00fcld\u00fc. \u00d6l\u00fcmlerin \u00e7o\u011fu, evde, i\u015fte veya uyku s\u0131ras\u0131nda g\u00fcnl\u00fck aktiviteler s\u0131ras\u0131nda meydana geldi. Sadece birka\u00e7 vaka yo\u011fun fiziksel eforla ili\u015fkilendirildi.<\/p>\n

Bu g\u00f6zlemler, kalp hastal\u0131klar\u0131n\u0131n yaln\u0131zca ya\u015fl\u0131lar\u0131 ilgilendirmedi\u011fini do\u011fruluyor. Gen\u00e7lerde de sa\u011fl\u0131ks\u0131z ya\u015fam al\u0131\u015fkanl\u0131klar\u0131 veya genetik yatk\u0131nl\u0131klar ciddi komplikasyonlara yol a\u00e7abilir. Genellikle bilinmeyen kardiyak hipertrofi, bu erken \u00f6l\u00fcmlerde kilit rol oynuyor.<\/p>\n

Yazarlar, risklerin erken de\u011ferlendirilmesinin gereklili\u011fi \u00fczerinde duruyor. Lund kalp a\u011f\u0131rl\u0131\u011f\u0131 hesaplay\u0131c\u0131s\u0131 gibi ara\u00e7lar, kalbin ger\u00e7ek a\u011f\u0131rl\u0131\u011f\u0131n\u0131 ya\u015f, cinsiyet ve boyuta g\u00f6re beklenen de\u011ferle kar\u015f\u0131la\u015ft\u0131rarak, risk alt\u0131ndaki ki\u015filerin belirlenmesine yard\u0131mc\u0131 olabilir. Uygun bir m\u00fcdahale, beslenme, sigaray\u0131 b\u0131rakma ve stres y\u00f6netimi konusunda \u00f6neriler i\u00e7eren, hayat kurtar\u0131c\u0131 olabilir.<\/p>\n

Bu \u00e7al\u0131\u015fma, koruman\u0131n erken ba\u015flamas\u0131 gerekti\u011fini hat\u0131rlat\u0131yor. \u00d6zellikle kalp hastal\u0131klar\u0131 \u00f6yk\u00fcs\u00fc olan gen\u00e7 yeti\u015fkinler d\u00fczenli takipten faydalanmal\u0131d\u0131r. Sa\u011fl\u0131k profesyonelleri, ince belirtilere kar\u015f\u0131 uyan\u0131k olmal\u0131 ve bu \u00f6nlenebilir \u00f6l\u00fcmleri azaltmak i\u00e7in daha sa\u011fl\u0131kl\u0131 ya\u015fam tarzlar\u0131n\u0131 te\u015fvik etmelidir.<\/p>\n

\n

Sources utilis\u00e9es<\/h2>\n

Source du rapport<\/h3>\n

DOI\u00a0:<\/strong> https:\/\/doi.org\/10.1007\/s12024-026-01197-7<\/a><\/p>\n

Titre\u00a0:<\/strong> Cardiac deaths with structural heart abnormalities in the young (0\u201349\u00a0years): a ten-year forensic autopsy review<\/p>\n

Revue : <\/strong> Forensic Science, Medicine and Pathology<\/p>\n

\u00c9diteur : <\/strong> Springer Science and Business Media LLC<\/p>\n

Auteurs : <\/strong> Lilly Landes; Stefanie Scheiper-Welling; Rina J\u00fcrgens; Marcel A. Verhoff; Silke Kauferstein; Eva Corvest<\/p>\n","protected":false},"excerpt":{"rendered":"

50 ya\u015f alt\u0131 gen\u00e7ler neden kalp hastal\u0131klar\u0131ndan \u00f6l\u00fcyor? Almanya’da on y\u0131l boyunca yap\u0131lan adli otopsilerin derinlemesine analizi, 50 ya\u015f alt\u0131ndaki do\u011fal \u00f6l\u00fcmlerin yakla\u015f\u0131k d\u00f6rtte birinin kalp k\u00f6kenli oldu\u011funu ortaya koyuyor. Bu vakalarda, \u00f6zellikle 40-49 ya\u015f aras\u0131 erkekleri etkileyen iskemik kalp hastal\u0131klar\u0131 ba\u015f\u0131 \u00e7ekiyor. Bu sonu\u00e7lar, erken kalp risklerinin daha iyi anla\u015f\u0131lmas\u0131n\u0131n ve buna g\u00f6re hareket… Okumaya devam et 50 ya\u015f alt\u0131 gen\u00e7ler neden kalp hastal\u0131klar\u0131ndan \u00f6l\u00fcyor?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-16","post","type-post","status-publish","format-standard","hentry","category-saglik","entry"],"_links":{"self":[{"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/posts\/16","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/comments?post=16"}],"version-history":[{"count":1,"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/posts\/16\/revisions"}],"predecessor-version":[{"id":17,"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/posts\/16\/revisions\/17"}],"wp:attachment":[{"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/media?parent=16"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/categories?post=16"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themedicaltribune.com\/tr\/wp-json\/wp\/v2\/tags?post=16"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}